March 26, 2020
Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients with its KL4 Surfactant Therapy
WARRINGTON, Pa., March 24, 2020 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical ...
Read More
March 26, 2020
Kuros Biosciences Reports Results for the Full Year 2019
SCHLIEREN (ZURICH), Switzerland, March 26, 2020 (GLOBE NEWSWIRE) -- Kuros Biosciences successfully delivered on its targets in 2019, increasing sales of MagnetOs fivefold and confirming ...
Read More
March 26, 2020
Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia
Saniona (SANION.ST), a clinical stage biopharmaceutical company focused on rare diseases of the central nervous system, today announced a new research collaboration with Boehringer Ingelheim ...
Read More
March 26, 2020
VBL Therapeutics Announces Positive Outcome of the Interim Analysis in the OVAL Phase 3 Ovarian Cancer Pivotal Study
TEL AVIV, Israel, March 26, 2020 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today announced an encouraging outcome of the planned interim analysis in the OVAL ...
Read More
March 26, 2020
Lipocine Announces Outcome of Markman Hearing in Patent Infringement Suit Against Clarus
SALT LAKE CITY, March 26, 2020 /PRNewswire/ -- Lipocine Inc.(NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that Judge William ...
Read More
March 26, 2020
Pluristem Provides Update on COVID-19: Preparedness, Current Phase III Clinical Trials Status and Treatment Development Activity
HAIFA, Israel, March 26, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI), a leading regenerative medicine company developing a platform of novel biological products, today ...
Read More
March 26, 2020
Intercept Pharmaceuticals Provides Regulatory and Business Update
NEW YORK, March 26, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to ...
Read More
March 26, 2020
SCYNEXIS to Virtually Present on the Candida Auris Treatment Landscape at the 22nd Annual Superbugs and Superdrugs Conference 2020
JERSEY CITY, N.J., March 26, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant ...
Read More
March 26, 2020
DarioHealth® Announces Key New Hires Expanding Its Management Depth in the Employer and Managed Care Markets
NEW YORK, March 26, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Omar Manejwala, M.D ...
Read More
March 26, 2020
Pulmatrix Reports 2019 Financial Results and Provides Business Update
LEXINGTON, Mass., March 26, 2020 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and ...
Read More
March 26, 2020
BioInvent Postpones the Annual General Meeting and Provides an Update on the Current Situation in Respect of COVID-19
LUND, Sweden, March 26, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV) today announces that the Board of Directors has resolved to postpone the ...
Read More
March 26, 2020
OSE Immunotherapeutics Reports 2019 Financial Results and Provides Business Update Expectations for Potential Impact of COVID-19 on the Company’s Clinical Development Activities
NANTES, France, March 26, 2020 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today reported its consolidated annual financial results for 2019 and provided ...
Read More
March 24, 2020
Valneva Provides Business Update on COVID-19 Situation
Saint Herblain (France), March 24, 2020 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, today provided an update on its operations as ...
Read More
March 24, 2020
Saniona Announces Management Transition to Support Strategic Transformation
Saniona (SANION.ST), a clinical stage biopharmaceutical company focused on rare diseases of the central nervous system, today announced the appointment of Anita Milland as interim ...
Read More
March 24, 2020
Oncolytics Biotech® Announces Favourable AWARE-1 Safety Update
SAN DIEGO, California and CALGARY, Alberta, March 24, 2020/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today ...
Read More
March 24, 2020
Capricor Therapeutics to Host a Key Opinion Leader Call On Why Exosomes are Uniquely Suited for Vaccine Development
LOS ANGELES, March 24, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the ...
Read More
March 24, 2020
Emmaus Life Sciences Provides Update in Response to the Coronavirus (COVID-19) Pandemic
TORRANCE, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (EMMA), a leader in sickle cell disease (SCD) treatment, announced today several steps ...
Read More
March 24, 2020
Menlo Therapeutics Appoints Andrew Saik as Chief Financial Officer
BRIDGEWATER, N.J., March 24, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (MNLO) (“Menlo” or the “Company”), a biopharmaceutical company focused on developing and commercializing proprietary ...
Read More
March 24, 2020
Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development
NEW YORK, March 24, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system ...
Read More
March 24, 2020
DarioHealth Enters Into a Partnership With Vitality to Accelerate Penetration Into the Self-insured Employer Market
NEW YORK, March 24, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario") a pioneer in the global digital therapeutics market, announced today that it has entered into a ...
Read More
Page 23 of 197